These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 9615733

  • 1. Opposing effects of suramin and DL-alpha-difluoromethylornithine on polyamine metabolism contribute to a synergistic action on B16 melanoma cell growth in vitro.
    Gritli-Linde A, Björkman U, Delle U, Hultborn R, Johansson BR, Nannmark U, Linde A.
    Anticancer Res; 1998; 18(2A):863-70. PubMed ID: 9615733
    [Abstract] [Full Text] [Related]

  • 2. Effects of suramin on polyamine metabolism in B16 murine melanoma cells.
    Gritli-Linde A, Björkman U, Delle U, Frostesjö L, Hultborn R, Hultén K, Johansson BR, Nannmark U, Linde A.
    Anticancer Res; 1998; 18(2A):855-62. PubMed ID: 9615732
    [Abstract] [Full Text] [Related]

  • 3. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.
    Sunkara PS, Chang CC, Prakash NJ, Lachmann PJ.
    Cancer Res; 1985 Sep; 45(9):4067-70. PubMed ID: 3928149
    [Abstract] [Full Text] [Related]

  • 4. Suramin selectively inhibits carcinoma cell growth that is dependent on extracellular polyamines.
    Sandgren S, Belting M.
    Anticancer Res; 2003 Sep; 23(2B):1223-8. PubMed ID: 12820375
    [Abstract] [Full Text] [Related]

  • 5. Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro.
    Takigawa M, Enomoto M, Nishida Y, Pan HO, Kinoshita A, Suzuki F.
    Cancer Res; 1990 Jul 01; 50(13):4131-8. PubMed ID: 1693880
    [Abstract] [Full Text] [Related]

  • 6. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice.
    Sunkara PS, Bowlin TL, Rosenberger AL, Fleischmann WR.
    J Biol Response Mod; 1989 Apr 01; 8(2):170-9. PubMed ID: 2499664
    [Abstract] [Full Text] [Related]

  • 7. Effects of treatments with alpha-difluoromethylornithine and hyperthermia on the growth and polyamine metabolism of Harding-Passey murine melanoma.
    Lopez Ballester JA, Peñafiel R, Cremades A, Valcarcel MM, Solano F, Lozano JA.
    Anticancer Res; 1991 Apr 01; 11(2):691-6. PubMed ID: 1905904
    [Abstract] [Full Text] [Related]

  • 8. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
    Heston WD, Fleischmann J, Tackett RE, Ratliff TL.
    Cancer Res; 1984 Aug 01; 44(8):3220-5. PubMed ID: 6430546
    [Abstract] [Full Text] [Related]

  • 9. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice.
    Sunkara PS, Rosenberger AL.
    Cancer Res; 1987 Feb 15; 47(4):933-5. PubMed ID: 3100031
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS, Prakash NJ, Rosenberger AL, Hagan AC, Lachmann PJ, Mayer GD.
    Cancer Res; 1984 Jul 15; 44(7):2799-802. PubMed ID: 6426786
    [Abstract] [Full Text] [Related]

  • 12. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
    Weeks RS, Vanderwerf SM, Carlson CL, Burns MR, O'Day CL, Cai F, Devens BH, Webb HK.
    Exp Cell Res; 2000 Nov 25; 261(1):293-302. PubMed ID: 11082299
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of three irreversible inhibitors of ornithine decarboxylase on macrophage-mediated tumoricidal activity and antitumor activity in B16F1 tumor-bearing mice.
    Bowlin TL, Hoeper BJ, Rosenberger AL, Davis GF, Sunkara PS.
    Cancer Res; 1990 Aug 01; 50(15):4510-4. PubMed ID: 2114941
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
    Xu H, Washington S, Verderame MF, Manni A.
    Breast Cancer Res Treat; 2008 Nov 01; 112(2):255-61. PubMed ID: 18097746
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.